Anavex Life Sciences
AVXL
#7563
Rank
HK$3.06 B
Marketcap
HK$34.25
Share price
-1.12%
Change (1 day)
-42.08%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -HK$4.45

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -HK$4.44. In 2024 the company made an earnings per share (EPS) of -HK$4.05 an increase over its 2023 EPS that were of -HK$4.67.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$4.459.87%
2024-HK$4.05-13.33%
2023-HK$4.67-3.23%
2022-HK$4.8314.81%
2021-HK$4.2020%
2020-HK$3.50-16.67%
2019-HK$4.2038.46%
2018-HK$3.0418.18%
2017-HK$2.57-21.43%
2016-HK$3.27-35.38%
2015-HK$5.06-36.27%
2014-HK$7.94112.5%
2013-HK$3.74-58.62%
2012-HK$9.03-0%
2011-HK$9.03-29.27%
2010-HK$12.7751.85%
2009-HK$8.41-0%
2008-HK$8.41237.5%
2007-HK$2.49
2006N/A-100%
2005-HK$0.31499.97%
2004-HK$0.05190

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
HK$18.61-519.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$0.39-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$7.78-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$474.86 10,601.75%๐Ÿ‡บ๐Ÿ‡ธ USA